Press Releases

Improving Medical Cannabis Programs Will Combat Opioid Crisis

Paul Marini | December 07, 2017

Americans for Safe Access Releases a Blueprint for State Policy WASHINGTON, DC — Today, Americans for Safe Access released “Medical Cannabis as a Tool to Combat Pain and the Opioid Crisis: A Blueprint for State Policy.” The blueprint outlines legislative and...

Read more

ASA Files Freedom of Information Act Requests

Paul Marini | November 09, 2017

WASHINGTON, DC — On November 9, Americans for Safe Access, filed two requests under the Freedom of Information Act (FOIA) for information on any discussions the Commission had about medical cannabis and specifically the only cannabis study referenced in the...

Read more

Medical Marijuana Study: 70 percent of CBD products inaccurately labelled

Paul Marini | November 07, 2017

Americans for Safe Access Co-Author’s Study in JAMA on Cannabidiol Products Washington, DC - A new study published this week in JAMA found that nearly 70 percent of all cannabidiol (CBD) products sold online are either over or under labeled,...

Read more

Patient Advocates Call on Congress to Act to Preserve Medical Cannabis to Fight Opiate Crisis

Paul Marini | October 31, 2017

Americans for Safe Access Launches Campaign and Declares November 1: National Cannabis as an Option for Pain Day WASHINGTON, DC — On November 1, Americans for Safe Access, the US Pain Foundation, and approximately 150 advocates will hold a press...

Read more

Trump Declares Opioid Crisis a Public Health Emergency, but Falls Short on Substance

Paul Marini | October 26, 2017

Americans for Safe Access to Launch National Campaign to Combat Opioid Deaths and Addiction Nov 1st WASHINGTON, DC — Today, President Trump declared the opioid crisis a public health emergency. While this is good news, this declaration does not carry the...

Read more

Medical Marijuana Expert Ethan Russo Joins Center of Excellence

Paul Marini | October 16, 2017

(Prague, 16th October 2017) International Cannabis and Cannabinoids Institute (ICCI) welcomes Ethan Russo, MD as the new Director of Research and Development. ICCI is the first-ever international Center of Excellence for the advancement of cannabis and cannabinoid treatments located in...

Read more

Councilmember David Grosso Sets Example for Local Leadership in Opioid Crisis

Paul Marini | September 20, 2017

Washington D.C. — District of Columbia Councilmember David Grosso introduced improvements to the nation’s capitol’s medical cannabis program yesterday, recognizing the power of cannabis to fight the opioid crisis. The Medical Marijuana Improvement Amendment Act of 2017 reduces major barriers...

Read more

House Committee Blocks Vote to Protect Medical Cannabis Patients

Paul Marini | September 07, 2017

U.S. House Committee on Rules Blocks Rohrabacher-Blumenauer Amendment Washington D.C. --  Last night, the House Committee on Rules voted to not allow a floor vote on an amendment which would continue to prevent the Department of Justice from using funds...

Read more

Massachusetts Medical Society Promotes Cannabis Education for Medical Professionals, Patient Advocates Hail Effort as a Huge Step Forward

Paul Marini | August 01, 2017

The Massachusetts Medical Society, a leader in continuing medical education (CME) providing accredited and certified activities across the globe for physicians and other health care professionals, endorsed the TheAnswerPage.com Comprehensive Cannabis Curriculum, as their comprehensive curriculum on the endocannabinoid system...

Read more

Senate Committee Stands Up for Medical Cannabis Patients

Paul Marini | July 27, 2017

U.S. Senate Committee on Appropriations Votes on Leahy Amendment Washington D.C. -- This morning, the Senate Committee on Appropriations voted to include an amendment introduced by Senator Patrick Leahy (D-VT) in the FY2018 Commerce, Justice, Science and Related Agencies Appropriations...

Read more